Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Pseudoephedrine recalled?

Not under an active recall. Pseudoephedrine was recalled 43 times in the past — all now closed. Most recent: Nov 21, 2022.

Most common reason: Dissolution failure (19 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Pseudoephedrine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Pseudoephedrine recalls on record

none so far in 2026; 43 on record, newest first
Class III · Low risk

Allergy Relief D

Failed dissolution specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 49032-273-20 D-0073-2023
Class III · Low risk

Leader

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 70000-0518-1 D-0386-2022
Class III · Low risk

CVS Health

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. D-0385-2022
Class III · Low risk

equate

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 49035-273-20 D-0383-2022
Class III · Low risk

Dr. Reddys

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. D-0382-2022
Class III · Low risk

Kroger

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 30142-611-14 D-0381-2022
Class III · Low risk

Rugby

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 0536-1242-07 D-0379-2022
Class III · Low risk

Wal-Fex D

Failed Dissolution Specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 0363-1606-20 D-0378-2022
Class III · Low risk

Fexofenadine HCl

Failed dissolution specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 43598-823-31 D-0275-2022
Class II · Moderate risk

Brompheniramine Maleate

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 60432-275-16 D-0596-2021